AgomAb Therapeutics NV · NASDAQ:AGMB

Epstein David R bought 10,000 AgomAb Therapeutics NV shares (Form 4)

Traded Oct 21, 2026 · Filed Oct 22, 2026

On Oct 21, 2026, Epstein David R (Director) bought 10,000 AgomAb Therapeutics NV shares at an average US$8.88 for US$88,800, leaving 25,000 shares. Filed Oct 22, 2026 (Form 4).

Bought
10,000 shares
Price
US$8.88 average (US$8.86 to US$8.90)
Value
US$88,800
Holding after
25,000 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 21, 2026Common sharesBuy5,000US$8.8620,000Direct
Oct 21, 2026Common sharesBuy5,000US$8.9025,000Direct

Source

Download original · View original at SEC

Related